Covalency-enabled Drug Discovery is Redefining Druggability

Medicinal Chemistry and Chemical Biology Highlights

Authors

  • Jeffrey M. McKenna Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, WSJ-088.10, CH-4056 Basel, Switzerland
  • Rupert Proctor Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, WSJ-088.10, CH-4056 Basel, Switzerland

DOI:

https://doi.org/10.2533/chimia.2023.537

Keywords:

Covalent, Cysteine targeting, Druggable proteins, Proteomics

Downloads

Published

2023-08-09

How to Cite

[1]
J. M. McKenna, R. S. J. Proctor, Chimia 2023, 77, 537, DOI: 10.2533/chimia.2023.537.

Issue

Vol. 77 No. 7/8 (2023): SCS Major Awards / SCS Fall Meeting 2023

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2023 Jeffrey M. McKenna, Rupert Proctor

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.